semaglutide shortage list FDA Ends Listing, Contributing to Ongoing Legal Challenges The Wegovy Shortage Continues, Leaving

Asia-Pacific is the fastest-growing regional GLP-1 drug market at 22.6% CAGR , driven by rapidly rising obesity prevalence China now reports 18.6% adult obesity prevalence up from 7.1% in 2000 combined with expanding private health insurance and regulatory approvals

Patience and Perspective Remember, weight loss isnt the only measure of success

Ikonomidis et al

The Triple Agonist Mechanism Explained Retatrutide is a single-molecule triple agonist that simultaneously activates three hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon

Over the past three months, the stock declined by 13.09% amid an uncertain backdrop